Luis Ortega-Paz

Assistant professor of Medicine

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Carlos Hermenegildo

University of Valencia

SPAIN

View details

Ana Paula Dantas

Serra Hunter Professor

University of Barcelona

SPAIN

View details

Susana Novella

Full Professor

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

Juan Sanchis

University of Valencia

SPAIN

View details

Dominick Joseph Angiolillo

University of Florida College of Medicine

UNITED STATES

View details

Pablo García de Frutos

Head of Department

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luis Ortega-Paz

Research Interests

Explore related searches

Contact this professor

Articles (10)

Circulating miRNA Fingerprint and Endothelial Function in Myocardial Infarction: Comparison at Acute Event and One-Year Follow-Up

Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction.

Cangrelor in Patients with Coronary Artery Disease Pre-treated with Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.

P2Y<sub>12</sub> Inhibitor Monotherapy after Percutaneous Coronary Intervention

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

Long-Term Vascular Function in CTO Recanalization: A Randomized Clinical Trial of Ticagrelor vs. Clopidogrel

Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes,Efectos cardiovasculares a medio plazo de la infección por SARS-CoV-2

Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention

Collaborators (6)

Carlos Hermenegildo

Ana Paula Dantas

Susana Novella

Juan Sanchis

Dominick Joseph Angiolillo

Pablo García de Frutos

Make your next move.